What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment-Reference-Cited by-同舟云学术

What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment

Published:2022-08-31 Issue:9 Volume:6 Page:e771
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Laurenti Luca,Gaidano Gianluca,Mauro Francesca Romana,Molica Stefano,Pasqualetti Patrizio,Scarfò Lydia,Ghia Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference15 articles.

1. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.;Eichhorst;Ann Oncol,2021

2. Treatment of chronic lymphocytic leukemia in older adults.;Rowswell-Turner;J Geriatr Oncol,2017

3. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.;Hallek;Am J Hematol,2019

4. Management of elderly and unfit patients with chronic lymphocytic leukemia.;Mauro;Expert Rev Hematol,2016

5. Chronic lymphocytic leukemia in the elderly: epidemiology and proposed patient-related approach.;Balducci;Cancer Control,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management;Nutrients;2024-09-05

2. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia;BMC Cancer;2024-07-11

3. Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment;Leukemia & Lymphoma;2024-07-09

4. Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities;HemaSphere;2024-07

5. Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints;Expert Review of Hematology;2024-06-13